6.56k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop speciality drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three-month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called ‘Battling Cancer’.
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.How are these weighted?
The stocks in this watchlist are weighted equally.
|Watchlist||Change today||1-month return||1-year return||Total return|
|Biotech and drug stocks||-1.27%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|JNJ||Johnson & Johnson||166.72||+0.54||+0.32%||4:00 pm GMT-4||9.18M||6.84M||438.34B|
|LLY||Eli Lilly and Company||311.46||+0.59||+0.19%||4:04 pm GMT-4||4.53M||2.55M||295.94B|
|RHHBY||Roche Holding AG||39.6||-0.44||-1.10%||3:59 pm GMT-4||1.66M||1.30M||260.37B|
|ABBV||AbbVie Inc.||143.06||+0.05||+0.03%||4:03 pm GMT-4||4.96M||5.38M||252.94B|
|PFE||Pfizer Inc.||44.08||-0.49||-1.10%||4:03 pm GMT-4||18.18M||17.71M||247.39B|
|NVO||Novo Nordisk A/S||97.93||-0.38||-0.39%||4:00 pm GMT-4||1.63M||1.65M||221.77B|
|MRK||Merck & Co., Inc.||86.78||-0.73||-0.83%||4:03 pm GMT-4||8.67M||8.59M||219.84B|
|AZN||AstraZeneca PLC||54.58||-1.73||-3.07%||4:00 pm GMT-4||9.59M||6.37M||173.22B|
|NVS||Novartis AG||76.01||-1.13||-1.46%||4:00 pm GMT-4||2.73M||2.15M||166.31B|
|BMY||Bristol-Myers Squibb Company||70.71||-0.58||-0.81%||4:00 pm GMT-4||7.73M||9.64M||150.98B|
|AMGN||Amgen Inc.||226.97||-0.78||-0.34%||4:00 pm GMT-4||2.15M||2.64M||121.41B|
|SNY||Sanofi||38.4||-0.73||-1.87%||4:00 pm GMT-4||3.40M||2.90M||97.20B|
|GILD||Gilead Sciences, Inc.||62.86||-0.91||-1.43%||4:00 pm GMT-4||7.60M||6.69M||78.79B|
|REGN||Regeneron Pharmaceuticals, Inc.||697.33||+9.07||+1.32%||4:00 pm GMT-4||815.88k||669.86k||76.01B|
|VRTX||Vertex Pharmaceuticals Incorporated||283.45||-2.89||-1.01%||4:00 pm GMT-4||1.35M||1.39M||72.69B|
|ZTS||Zoetis Inc.||150.05||+0.59||+0.39%||4:05 pm GMT-4||1.60M||1.66M||70.24B|
|GSK||GSK plc||29.36||-0.65||-2.17%||4:00 pm GMT-4||9.04M||6.52M||60.25B|
|MRNA||Moderna, Inc.||123.64||-0.68||-0.55%||4:00 pm GMT-4||3.94M||4.86M||48.37B|
|BAYRY||Bayer Aktiengesellschaft||12.09||-0.64||-5.03%||3:59 pm GMT-4||884.29k||720.81k||47.92B|
|TAK||Takeda Pharmaceutical Company Limited||13||-0.16||-1.22%||4:00 pm GMT-4||2.94M||2.40M||41.15B|
|BNTX||BioNTech SE||128.35||-1.65||-1.27%||4:00 pm GMT-4||995.28k||945.25k||31.15B|
|BIIB||Biogen Inc.||197.78||-2.84||-1.42%||4:00 pm GMT-4||1.44M||906.21k||28.70B|
|HLN||Haleon plc||5.93||-0.14||-2.31%||4:00 pm GMT-4||4.82M||9.54M||27.64B|
|RPRX||Royalty Pharma plc||40.33||-0.73||-1.78%||4:00 pm GMT-4||1.74M||1.86M||27.26B|
|SGEN||Seagen Inc.||139.2||-1.35||-0.96%||4:00 pm GMT-4||925.56k||1.10M||25.67B|
|ALNY||Alnylam Pharmaceuticals, Inc.||200.78||-1.93||-0.95%||4:00 pm GMT-4||544.88k||1.03M||24.10B|
|GMAB||Genmab A/S||31.83||-1.51||-4.53%||4:00 pm GMT-4||754.41k||575.79k||21.66B|
|ARGX||argenx SE||343.2||-13.51||-3.79%||4:00 pm GMT-4||217.27k||266.10k||19.63B|
|BMRN||BioMarin Pharmaceutical Inc.||84.84||-0.08||-0.09%||4:00 pm GMT-4||994.83k||970.79k||15.74B|
|INCY||Incyte Corporation||66.89||-0.52||-0.77%||4:00 pm GMT-4||1.31M||1.37M||14.88B|
The bear market is poised for a new leg down as selling intensifies. Apple, Eli Lilly are stocks showing relative strength.
Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. "I’m feeling well and symptom free," Bourla said in a statement. Bourla, 60, back in August had contacted COVID and had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid.
"I’m feeling well and symptom free," Bourla said in a statement. Bourla, 60, back in August had contacted COVID and had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid. Paxlovid is an antiviral medication that is used to treat high-risk people, such as older patients.